NIH awards National Jewish Health $31 million to lead study of infections associated with eczema

NIH awards National Jewish Health million to lead study of infections associated with eczema
( National Jewish Health ) National Jewish Health has received million form the NIH to lead a study of infections associated with eczema. Antibiotic-resistant staph infections, which are both a public health problem and particular scourge of eczema patients, will be a major focus of the study. Atopic dermatitis is the most common skin disease in the US, afflicting about 20 percent of children.
Read more on EurekAlert!

Study shows osteocalcin plays role in diabetes onset
Researchers led by Columbia University Medical Center have discovered that the skeleton plays an important role in regulating blood sugar and have further illuminated how bone controls this process. The finding, published in Cell, is important because it may lead to more targeted drugs for type 2 diabetes.
Read more on News-Medical-Net

Pennington Biomedical Research Institute and Compellis Pharmaceuticals Complete Phase I Study of Novel and Patented …
BOSTON, MA–(Marketwire – 07/22/10) – Compellis Pharmaceuticals, Inc., an early-stage pharmaceutical company developing novel mechanism-based therapeutics for the treatment of obesity, announced today with its collaborator Pennington Biomedical Research Institute at Louisiana State University, that they have successfully completed a human Phase I pilot clinical trial. Study subjects were given …
Read more on Marketwire via Yahoo! Finance